Pharmaceutical

Global Cardiovascular Drug Market Research and Forecast 2018-2023

October 22, 2018 by OMRGlobal

Global Cardiovascular drug Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

Cardiovascular disease (CVD) involves heart and blood vessel blockage which leads to heart attack, chest pain and other heart problems.  It is one of the leading cause of death worldwide. CVD mainly caused due to high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol consumption. Factors motivating the growth of cardiovascular drug market includes increasing geriatric population and changing lifestyle such as shift in work hours. Advancement in cardiovascular diagnosis procedure and technological improvement in the healthcare have fuelled the growth of this market. Growing healthcare expenditure in emerging economies and cost-effective and affordable cardiovascular solution by leading manufacturers have provided new opportunity to this market.


Geographically, Cardiovascular drug market is divided into North America, Europe, Asia Pacific and Rest of the World. In terms of revenue generation North America region represents the largest market for cardiovascular drugs. Adoption of genetic engineering in U.S for diagnosis of cardiovascular diseases is another driving factor. Increasing government funding to improve healthcare infrastructure, and rising awareness about cardiovascular drug are the major factor which drives this market in APAC region.

The global players in the cardiovascular drug market include Abbott laboratories, Bristol-Myers Squibb company, Sanofi, Boston scientific, C.R bard. The strategy adopted in these companies are continuous investments in (R&D) which made them progress over the past several years in offering better drug with minimum side effects. As a result, market player may offer low-cost, high-value solutions and services to various community hospitals and clinics. In January 2018, Sanofi acquired Ablynx to expand their product portfolio for rare blood disorders and continue to advance the strategic transformation for drug discovery.

The report covers:
  • Comprehensive research methodology of Global Cardiovascular drug market.
  • This report also includes detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key                                 recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Cardiovascular           drug market.
  • Insights about market determinants which are stimulating the Global Cardiovascular drug market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

For related reports please visit: Pharmaceuticals Industry



Contact us

Orion Market Research Pvt. Ltd.
Indore – India- 452010
India: +91-780-304-0404, +91-917-982-8694
Global: +1-646-755-7667
0 Comments

0 Comments

Post a Comment